CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CORT is currently covered by 5 analysts with an average price target of $88.85. This is a potential upside of $18.33 (25.99%) from yesterday's end of day stock price of $70.52.

Corcept Therapeutics's activity chart (see below) currently has 47 price targets and 77 ratings on display. The stock rating distribution of CORT is 7.69% HOLD and 92.31% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.9% with an average time for these price targets to be met of 256 days.

Highest price target for CORT is $145, Lowest price target is $131, average price target is $114.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 06-May-2025. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of CORT, 3 are a HOLD (7.69%), 36 are a BUY (92.31%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$145

$77.83 (115.87%)

$150

3 months ago
(06-May-2025)

15/19 (78.95%)

$74.26 (104.98%)

134

Buy

$131

$63.83 (95.03%)

$78

4 months 3 days ago
(03-Apr-2025)

7/8 (87.5%)

$51.63 (65.05%)

86

Buy

$142

$74.83 (111.40%)

$130

4 months 5 days ago
(01-Apr-2025)

7/9 (77.78%)

$50.07 (54.47%)

290

Buy

$38

$13.94 (57.94%)

$29

1 years 9 months ago
(06-Nov-2023)

2/3 (66.67%)

$12.09 (46.66%)

37

Hold

$29

$-38.17 (-56.83%)

$26

2 years 3 days ago
(03-Aug-2023)

4/4 (100%)

$-2.24 (-7.17%)

262

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 256 days on average for the stock forecasts to be realized with a an average price target met ratio 91.9

Which analyst has the current highest performing score on CORT (Corcept Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth has 3 price targets and 6 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $77.83

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

David Buck with lowest potential downside - -$56.17

Corcept Therapeutics in the News

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

Corcept Therapeutics CORT reported second-quarter 2025 earnings of 29 cents per share, which beat the Zacks Consensus Estimate of 23 cents. The company had reported earnings of 32 cents per share in the year-ago quarter. Revenues in the second quarter increased 18.7% year over year to $194.4 million. The figure, however, missed the Zacks Consensus...

Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates

Corcept Therapeutics (CORT) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.32 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +26.09%. A quarter ago, it was expected that...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?